| Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial J Aman, E Duijvelaar, L Botros, A Kianzad, JR Schippers, PJ Smeele, ... The Lancet Respiratory Medicine 9 (9), 957-968, 2021 | 110 | 2021 |
| SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction MA de Raaf, I Schalij, J Gomez-Arroyo, N Rol, C Happé, FS de Man, ... European Respiratory Journal 44 (1), 160-168, 2014 | 106 | 2014 |
| Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension N Rol, MA de Raaf, XQ Sun, VP Kuiper, D da Silva Gonçalves Bos, ... Cardiovascular research 115 (2), 432-439, 2019 | 44 | 2019 |
| Placental effects and transfer of sildenafil in healthy and preeclamptic conditions E Hitzerd, M Broekhuizen, KMM Colafella, M Glisic, R de Vries, BCP Koch, ... EBioMedicine 45, 447-455, 2019 | 43 | 2019 |
| Endothelin-1 receptor antagonists in fetal development and pulmonary arterial hypertension MA de Raaf, M Beekhuijzen, C Guignabert, AV Noordegraaf, HJ Bogaard Reproductive Toxicology 56, 45-51, 2015 | 42 | 2015 |
| Histone deacetylase inhibition with trichostatin A does not reverse severe angioproliferative pulmonary hypertension in rats (2013 Grover Conference series) MAD Raaf, AA Hussaini, JG Gomez-Arroyo, D Kraskaukas, D Farkas, ... Pulmonary Circulation 4 (2), 1-7, 2014 | 35 | 2014 |
| Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats CM Happé, MA De Raaf, N Rol, I Schalij, A Vonk-Noordegraaf, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 310 …, 2016 | 30 | 2016 |
| Long-term clinical outcomes of COVID-19 patients treated with imatinib E Duijvelaar, JR Schippers, PJ Smeele, MA de Raaf, ALEM Vanhove, ... The Lancet Respiratory Medicine 10 (4), e34-e35, 2022 | 26 | 2022 |
| Serotonin transporter is not required for the development of severe pulmonary hypertension in the Sugen hypoxia rat model MA De Raaf, Y Kroeze, A Middelman, FS de Man, H de Jong, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 309 …, 2015 | 24 | 2015 |
| DNGR1-Cre–mediated Deletion of Tnfaip3/A20 in Conventional Dendritic Cells Induces Pulmonary Hypertension in Mice T Koudstaal, JAC van Hulst, T Das, SFH Neys, D Merkus, IM Bergen, ... American journal of respiratory cell and molecular biology 63 (5), 665-680, 2020 | 21 | 2020 |
| Tyrosine kinase inhibitor BIBF1000 does not hamper right ventricular pressure adaptation in rats MA De Raaf, FE Herrmann, I Schalij, FS de Man, A Vonk-Noordegraaf, ... American Journal of Physiology-Heart and Circulatory Physiology 311 (3 …, 2016 | 14 | 2016 |
| A critical evaluation of thyroid hormone measurements in OECD test guideline studies: is there any added value? M Beekhuijzen, JCW Rijk, M Meijer, MA de Raaf, S Pelgrom Reproductive Toxicology 88, 56-66, 2019 | 13 | 2019 |
| The underestimated value of OECD 421 and 422 repro screening studies: putting it in the right perspective M Beekhuijzen, MA de Raaf, A Zmarowski, F van Otterdijk, B Peter, ... Reproductive Toxicology 48, 81-87, 2014 | 11 | 2014 |
| Caspase inhibition stabilizes progressive vascular remodeling in established pulmonary hypertension CM Happé, R Szulcek, N Rol, MA De Raaf, I Schalij, A Vonk-Noordegraaf, ... European Respiratory Journal 46 (suppl 59), 2015 | 2 | 2015 |
| Pneumonectomy combined with SU5416 induces severe angio-obliterative pulmonary hypertension in rats CM Happe, MA De Raaf, I Schalij, D Bos, A Vonk-Noordegraaf, ... B58. EXPERIMENTAL MODELS OF PULMONARY HYPERTENSION II, A3336-A3336, 2014 | 1 | 2014 |
| 90-Day Clinical Outcome of Hospitalized Covid-19 Patients Treated with Imatinib J Schippers, E Duijvelaar, P Smeele, M De Raaf, S Blok, A Vanhove, ... D17. TOP KNOWLEDGE IN COVID, A5048-A5048, 2022 | | 2022 |
| Late Breaking Abstract-A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19 J Aman, E Duijvelaar, L Botros, A Kianzad, J Schippers, P Smeele, ... European Respiratory Journal 58 (suppl 65), 2021 | | 2021 |
| Imatinib in patients with severe COVID-19: a randomised, doubleblind, placebo-controlled, clinical trial (vol 9, pg 957, 2021) J Aman, E Duijvelaar, L Botros, A Kianzad, JR Schippers, PJ Smeele, ... The Lancet Respiratory Medicine 9 (8), E82-E82, 2021 | | 2021 |
| Correction to Lancet Respir Med 2021; published online June 17, https://doi. org/10.1016/S2213-2600 (21) 00237-X (The Lancet Respiratory Medicine,(S221326002100237X),(10.1016 … J Aman, E Duijvelaar, L Botros, A Kianzad, JR Schippers, PJ Smeele, ... Lancet respiratory medicine 9 (8), e84, 2021 | | 2021 |
| The need for hypoxic exposure in experimental PAH-Comment on Chen et al.: a novel rat model of pulmonary hypertension induced by mono treatment with SU5416 MA de Raaf, I Schalij, HJ Bogaard Hypertension Research 43 (11), 1313-1314, 2020 | | 2020 |
